Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

International Business Machines Corporation (IBM): Smart Money Ownership Hits 3-Year Low

How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. They don’t always get it right, but, on average, their stock picks historically generated strong returns after adjusting for known risk factors. With this in mind, let’s take a look at the recent hedge fund activity surrounding International Business Machines Corporation (NYSE:IBM).

More and more hedge funds are losing faith in International Business Machines Corporation (NYSE:IBM). IBM shares hit a 3-year low during Q3 in terms of how many hedge funds own them, sliding to just 43 with long positions on September 30. That figure was slightly over 60 just a year-and-a-half earlier. With hedge fund ownership of IBM having fallen sharply in 2018, the stock has plummeted to the 159th most-owned holding among hedge funds, falling well short of our list of the 30 Most Popular Stocks Among Hedge Funds.

According to most market participants, hedge funds are seen as slow, old investment tools of the past. While there are more than 8,000 funds with their doors open at the moment, our researchers hone in on the crème de la crème of this group, around 700 funds. These money managers direct the lion’s share of all hedge funds’ total capital, and by observing their unrivaled stock picks, Insider Monkey has revealed several investment strategies that have historically defeated the market. Insider Monkey’s flagship hedge fund strategy defeated the S&P 500 index by 6 percentage points per annum since its inception in May 2014 through early November 2018. We were able to generate large returns even by identifying short candidates. Our portfolio of short stocks lost 26.1% since February 2017 even though the market was up nearly 19% during the same period. We just shared a list of 11 short targets in our latest quarterly update.


Hedge fund activity in International Business Machines Corporation (NYSE:IBM)

At Q3’s end, a total of 43 of the hedge funds tracked by Insider Monkey were long this stock, a 7% drop from the second quarter of 2018. Below, you can check out the change in hedge fund sentiment towards IBM over the last 13 quarters. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.


More specifically, AQR Capital Management was the largest shareholder of International Business Machines Corporation (NYSE:IBM), with a stake worth $641.5 million reported as of the end of September. Trailing AQR Capital Management was Arrowstreet Capital, which amassed a stake valued at $279.3 million. Citadel Investment Group, Adage Capital Management, and Renaissance Technologies were also very fond of the stock, giving the stock large weights in their portfolios.

Seeing as International Business Machines Corporation (NYSE:IBM) has experienced a decline in interest from the aggregate hedge fund industry, it’s safe to say that there is a sect of fund managers who sold off their positions entirely last quarter. Interestingly, Israel Englander’s Millennium Management sold off the biggest stake of the 700 funds monitored by Insider Monkey, valued at close to $105.8 million in stock. Prem Watsa’s fund, Fairfax Financial Holdings, also dropped its stock, about $37.1 million worth. These moves are interesting, as aggregate hedge fund interest dropped by 3 funds last quarter.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as International Business Machines Corporation (NYSE:IBM) but similarly valued. These stocks are NIKE, Inc. (NYSE:NKE), Amgen, Inc. (NASDAQ:AMGN), Medtronic plc (NYSE:MDT), and BHP Billiton Limited (NYSE:BHP). This group of stocks’ market caps resemble IBM’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
NKE 46 1918057 10
AMGN 42 2892393 3
MDT 53 2507997 18
BHP 19 617958 7

As you can see these stocks had an average of 40 hedge funds with bullish positions and the average amount invested in these stocks was $1.98 billion. That figure was $1.54 billion in IBM’s case. Medtronic plc (NYSE:MDT) is the most popular stock in this table. On the other hand BHP Billiton Limited (NYSE:BHP) is the least popular one with only 19 bullish hedge fund positions. International Business Machines Corporation (NYSE:IBM) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on, like MDT.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.